Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus their energies on developing their big-selling Jardiance pill.
Eli Lilly upped its guidance for 2019 after posting strong third quarter results, as more recently released drugs offset sales lost as former erectile dysfunction blockbuster Cialis lost pa
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
